Literature DB >> 7840987

Value of two-dimensional echocardiography for determining the basis of hemodynamic compromise in critically ill patients: a prospective study.

S Kaul1, A A Stratienko, S G Pollock, M A Marieb, M W Keller, P J Sabia.   

Abstract

We postulated that because the first step in the management of critically ill patients with hypotension, pulmonary edema, or both is to determine whether the cause is cardiac or noncardiac, direct visualization of the heart with two-dimensional echocardiography would be useful for determining the basis of hemodynamic compromise in such patients. Accordingly, 49 consecutive patients (33 men and 16 women; mean age 61 +/- 15 years) underwent two-dimensional echocardiography within 2 hours of placement of a pulmonary artery flotation catheter for determining the reason for hypotension, pulmonary edema, or both. To discriminate between cardiac and noncardiac causes, hemodynamic and two-dimensional echocardiographic data were evaluated independently by two to three blinded interpreters based on predetermined criteria. There was complete agreement between pulmonary artery catheter and two-dimensional echocardiographic data in 36 (86%) of the 42 patients in whom interpretable data were available in terms of cardiac versus noncardiac causes. The two modalities agreed in all patients with hypotension alone and disagreed in 2 of the 20 patients with pulmonary edema alone and 4 of the 14 patients with combined hypotension and pulmonary edema. In cases of discordance, the two tests provided complimentary information, particularly in patients with sepsis in whom the stroke volume may be normal to high but left ventricular systolic function may be depressed. The time taken for pulmonary artery catheter placement was 63 +/- 45 minutes versus 19 +/- 7 minutes for two-dimensional echocardiography.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7840987     DOI: 10.1016/s0894-7317(14)80082-5

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  8 in total

1.  A validation study of electrical cardiometry in pregnant patients using transthoracic echocardiography as the reference standard.

Authors:  Erin Martin; Adanna Anyikam; Jerasimos Ballas; Kristen Buono; Kristin Mantell; Thao Huynh-Covey; Thomas Archer
Journal:  J Clin Monit Comput       Date:  2015-09-24       Impact factor: 2.502

2.  Echocardiography in the ICU: time for widespread use!

Authors:  Bernard P Cholley; Antoine Vieillard-Baron; Alexandre Mebazaa
Journal:  Intensive Care Med       Date:  2005-11-16       Impact factor: 17.440

3.  Feasibility and influence of hTEE monitoring on postoperative management in cardiac surgery patients.

Authors:  S Treskatsch; F Balzer; F Knebel; M Habicher; J P Braun; M Kastrup; H Grubitzsch; K-D Wernecke; C Spies; M Sander
Journal:  Int J Cardiovasc Imaging       Date:  2015-06-06       Impact factor: 2.357

Review 4.  'Combat' Approach to Cardiogenic Shock.

Authors:  Alexander G Truesdell; Behnam Tehrani; Ramesh Singh; Shashank Desai; Patricia Saulino; Scott Barnett; Stephen Lavanier; Charles Murphy
Journal:  Interv Cardiol       Date:  2018-05

Review 5.  Approach to the patient with the acute respiratory distress syndrome.

Authors:  David R Janz; Lorraine B Ware
Journal:  Clin Chest Med       Date:  2014-09-26       Impact factor: 2.878

Review 6.  Echocardiographic hemodynamic monitoring in the critically ill patient.

Authors:  Francisco J Romero-Bermejo; Manuel Ruiz-Bailen; Manuel Guerrero-De-Mier; Julian Lopez-Alvaro
Journal:  Curr Cardiol Rev       Date:  2011-08

7.  Dynamic left ventricular outflow tract obstruction without basal septal hypertrophy, caused by catecholamine therapy and volume depletion.

Authors:  Ji Hyun Yang; Seung Woo Park; Jeong Hoon Yang; Sung Won Cho; Hyo Song Kim; Kyoung A Choi; Ho Joong Kim
Journal:  Korean J Intern Med       Date:  2008-06       Impact factor: 2.884

Review 8.  Echocardiography in shock management.

Authors:  Anthony S McLean
Journal:  Crit Care       Date:  2016-08-20       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.